Analyst Ratings for AstraZeneca PLC ADR (AZN)

Updated: 2017-07-26

An average rating of Overweight has been given to AstraZeneca PLC ADR (NYSE:AZN) by analysts covering the stock. A consensus rating of Overweight was previously issued for AZN last month.

18 analysts declared AZN a buy, 2 gave an overweight rating, 14 gave a hold rating, 1 gave an underweight rating, and 4 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 2. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for AZN by the analysts covering the stock. The most optimistic price target was 51.55, which equates to a potential upside of 52.74 percent. The lowest price target was 25, which equates to a potential downside of -25.93 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Analysts have revised their earnings estimates downwards for this quarter, by about -5.73 percent on average, compared to last month. That number becomes -4.6 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised downwards by -0.54 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.1 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, compared to 3 analysts that revised their FY estimates downwards.

The growth rate of AZN's earnings is estimated by analysts to be 50.63 percent. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. AZN has a PEG ratio of 0.55.

AZN has traded between a high of 35.60 and a low of 25.55 over the past year. Today's price is 32.09 percent above the 52-week low, and below the high by 5.2 percent. AZN has a price/earnings ratio of 27.61. Investors typically compare the P/E ratio to a company's peers in the industry. The AZN value stock report compares AZN to some of its peers using value stock charts. The market cap of AZN is $84.02 billion. AZN will post this quarters earnings in days, on 0000-00-00.